Executives On The Move: Departures From Pfizer And Bavarian Nordic, And New Sales Leadership For An Asian Markets Biopharma
VP, clinical development at Pfizer Oncology heads for global rare disease/oncology firm EUSA Pharma and Bavarian Nordic CMO switches to genome editing company Precision BioSciences. Former VP for Roche Pharma China becomes chief commercial officer for Asian-market focused Everest Medicines.
You may also be interested in...
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.
Japanese big pharma Eisai taps Celgene and Sanofi execs as its new VPs for corporate affairs and market access. And Freeline Therapeutics, developer of gene therapies for bleeding disorders, selects a former Alnylam Pharma SVP as CEO.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.